Stem cells for the heart, are we there yet?

F Timmermans1, J De Sutter, T C Gillebert

  • 1Department of Cardiovascular Diseases, Ghent University, Ghent, Belgium. timmermansfrank1973@hotmail.com

Cardiology
|January 10, 2004
PubMed

Insights

Bone marrow stem cells show promise for repairing heart damage after myocardial infarction. This therapy could prevent heart failure, offering a new strategy for cardiac regeneration in humans.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Stem Cell Therapy

Background:

  • Despite advances, myocardial infarction (MI) complications like chronic heart failure remain a significant global health issue.
  • Existing cardiac repair mechanisms are insufficient to prevent heart disease in most pathological conditions.
  • Post-MI heart failure continues to be a major worldwide health concern.

Purpose of the Study:

  • To review the potential of bone marrow stem cells for cardiac regeneration following myocardial infarction.
  • To discuss critical considerations for future human clinical trials involving stem cell therapy for heart repair.

Main Methods:

  • Review of existing scientific literature on stem cell therapy and cardiac regeneration.
  • Analysis of evidence supporting bone marrow stem cell differentiation into cardiomyocytes.
  • Discussion of challenges and opportunities in translating stem cell therapy to human trials.

Main Results:

  • Growing evidence suggests bone marrow stem cells, including mesenchymal stem cells, can generate new cardiomyocytes in both animal models and humans.
  • Stem cell therapy presents a promising strategy to restore cardiac function after MI and prevent congestive heart failure.
  • Key issues for human trials regarding efficacy and safety are being identified.

Conclusions:

  • Bone marrow stem cell therapy holds significant potential for treating myocardial infarction and preventing heart failure.
  • Further research and careful consideration of issues are paramount for successful human clinical trials in cardiac regeneration.
  • Stem cell therapy represents a promising frontier in cardiovascular medicine for heart repair.

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.